Immune system study for ovarian cancer
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how the immune system works in people with epithelial ovarian cancer. It aims to understand the immune landscape around the tumor, which could lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a suspected or confirmed diagnosis of epithelial ovarian cancer.
- You must be scheduled for surgery to treat your ovarian cancer or a recurrence.
- You must be able to perform daily activities with minimal assistance (ECOG score of 0–2).
- You cannot have another active cancer that might affect the study results.
- You cannot have an active autoimmune disease or be on long-term steroids or immune-suppressing medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune-related markers in people with ovarian cancer to see if they can help predict prognosis (how the cancer may behave). If you qualify, your doctors may use your immune test results alongside other standard treatments like surgery, chemotherapy, and/or immunotherapy.
This study looks at whether changes in immune system markers in the blood can help detect if ovarian cancer comes back after treatment. It tests standard chemotherapy and surgery, with the goal of improving how doctors monitor the disease.
This trial tests a personalized vaccine for people with epithelial ovarian cancer who still have a small amount of cancer DNA in their blood after surgery. The goal is to see if the vaccine can help stop the cancer from coming back.
This study uses whole-body scans to look at how active tumors are in women with suspected ovarian cancer. The goal is to see if these scans can predict how well treatment will work, which may help personalize care.
This trial tests whether adding immunotherapy (a treatment that boosts your immune system) to surgery helps people whose ovarian cancer has returned and is sensitive to chemotherapy. It aims to see if this combination can improve outcomes for patients with certain biomarkers.
This study looks back at different surgical methods (open or minimally invasive) used for early-stage epithelial ovarian cancer. It aims to compare outcomes and help doctors choose the best approach.
Hear when a new Epithelial Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.